Epilepsy News and Research

Latest Epilepsy News and Research

Quintiles and Eisai partner to develop potential oncology products

Quintiles today announced a strategic alliance with leading global pharmaceutical company Eisai Co., Ltd. (Tokyo, Japan) to develop six potential oncology products in Eisai’s R&D pipeline. Under the terms of the agreement, Quintiles’ oncology experts will conduct Phase II proof-of-concept studies for 11 solid tumor indications. A key goal of the alliance is to determine the efficacy of the products in the shortest possible time in order to bring therapies to market faster for the benefit of cancer patients worldwide.

31 Oct 2009

New teleneurology medicine program to provide 24-hour emergency services launched

Rural and small, suburban hospitals in North Carolina and Virginia can now provide a higher level of emergency stroke and critical neurology care, 24 hours a day, 365 days a year, as part of a new teleneurology medicine program announced Oct. 26, 2009, by Forsyth Medical Center (FMC).

31 Oct 2009

Eisai reports global Phase III study results of eribulin mesylate

Eisai Inc. today announced preliminary results from a recently completed Phase III study with eribulin mesylate (E7389), discovered and developed by the company, in patients with locally advanced or metastatic breast cancer.

30 Oct 2009

Child Neurology Foundation raises $30,000 during Infantile Spasms Awareness Week

The Child Neurology Foundation (CNF) today announced that $30,000 was raised during Infantile Spasms Awareness Week (October 11-17) that will go towards researching the cause and treatment of this ultra-rare form of epilepsy.

28 Oct 2009

ACC's initiative for health care reform

As lawmakers debate health care reform, business innovator Lou Weisbach and Clinton White House health care advisor Dr. Richard Boxer are available for interviews to discuss a glaring, missing element of the forthcoming health care legislation: reducing health care costs -- and saving lives -- by preventing and curing disease.

27 Oct 2009

Genetic mutations cause for SIDS and SUDS

Scientists and clinicians at the Montefiore-Einstein Center for Cardiogenetics have teamed up and found that genetic mutations leading to Long QT Syndrome (LQTS) could be causing electrical malfunctioning of the heart resulting in the mysterious deaths more commonly known as Sudden Infant Death Syndrome (SIDS) and Sudden Unexplained Death Syndrome (SUDS) in people older than 12 months of age.

27 Oct 2009

Protein crucial for insulin regulation may play a role in diabetes

A cellular protein from a family involved in several human diseases is crucial for the proper production and release of insulin, new research has found, suggesting that the protein might play a role in diabetes.

27 Oct 2009

Deep brain stimulation: New treatment option for people with severe Tourette syndrome

Deep brain stimulation may be a safe and effective treatment for Tourette syndrome, according to research published in the October 27, 2009, print issue of Neurology®, the medical journal of the American Academy of Neurology.

27 Oct 2009

TV program shares insights on epilepsy, diagnosis and treatment

A recent edition of Immunotherapy Weekly reported that the television program 'Sharing Miracles' featured award-winning actor Danny Glover during the month of September. In this episode, the Hollywood star discussed his career and his battle against epilepsy.

24 Oct 2009

Epilepsy Therapy Project unveils My Epilepsy Diary

Epilepsy Therapy Project, a leader in accelerating new therapies for people living with epilepsy and seizures, announces the release of My Epilepsy Diary, a breakthrough data-gathering and reporting product designed to improve epilepsy care and quality of life.

19 Oct 2009

NICoE to study how brain works after sustaining combat-related injury using Elekta Neuromag

Projected to open in mid 2010, the National Intrepid Center of Excellence (NICoE) is a facility dedicated to the study and care of military personnel and veterans suffering from traumatic brain injury (TBI) and psychological health issues. Using Elekta Neuromag®, an advanced magnetoencephalography (MEG) device, NICoE plans to shed light on how the brain works after sustaining combat-related injury.

From Elekta 15 Oct 2009

Brain researcher finds how the epilepsy and pain drug works

A Duke University Medical Center researcher who spent years looking for the signals that prompt the brain to form new connections between neurons has found one that may explain precisely how a well-known drug for epilepsy and pain actually works.

14 Oct 2009

Guidelines for treating amyotrophic lateral sclerosis identified

New guidelines from the American Academy of Neurology identify the most effective treatments for amyotrophic lateral sclerosis (ALS), often called Lou Gehrig's disease. The guidelines are published in the October 13, 2009, issue of Neurology®, the medical journal of the American Academy of Neurology.

13 Oct 2009

CNF launches new educational website centered on infantile spasms

The Child Neurology Foundation (CNF) today announced the launch of a new educational website centered on infantile spasms (IS). The website, www.infantilespasmsinfo.org, is an educational resource developed by the CNF as one of the key components of Infantile Spasms Awareness Week.

12 Oct 2009

Depomed announces results from BREEZE 1 and 2 Phase 3 clinical trials of Serada

Depomed, Inc. announced today top-line results from the BREEZE 1 and 2 Phase 3 clinical trials evaluating the safety and efficacy of SeradaTM, an investigational non-hormonal extended release formulation of gabapentin for the treatment of menopausal hot flashes.

12 Oct 2009

Three hundred participants sought for world-first study to determine shared biological basis for psychotic illnesses

For the first time, sufferers of schizophrenia and bipolar disorder are being brought together in a major new study investigating the diseases' common genetic causes and manifestations.

11 Oct 2009

Scientists make significant advance towards a solution for neuronal repair

The repair of damaged nerve cells is a major problem in medicine today. A new study by researchers at the Montreal NeurologicaI Institute and Hospital (The Neuro) and McGill University, is a significant advance towards a solution for neuronal repair.

8 Oct 2009

Catalyst Pharmaceutical raises $3.97 million from institutional investors

Catalyst Pharmaceutical Partners, Inc. today announced that it has closed its previously announced registered direct offering of 3.97 million shares of its common stock to institutional investors at a price per share of $1.00, representing gross proceeds of $3.97 million.

7 Oct 2009

U.S. lags behind industrialized countries on preventable deaths

The United States lags behind other wealthy countries on "preventable deaths," those caused by illnesses and injuries that should not kill at an early age, and it has been falling further behind over the past decade.

6 Oct 2009

National experts to address epilepsy disorder

The Epilepsy Foundation of Minnesota is partnering with Mayo Clinic to host a regional patient education conference called “Living with Seizures: Today & Tomorrow.” The regional conference will feature national experts in epilepsy, panel discussions and breakout sessions that include the following topics:

5 Oct 2009